← Back to all trials
Recruiting
NCT07491094
Repeated Examinations for Typing Pulmonary Embolism
Conditions: Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute, Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism With Right Ventricle Enlargement, Pulmonary Embolism (PE)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 400
Sponsor: Sahlgrenska University Hospital
Location: Sahlgrenska University Hospital/Mölndal Gothenburg Region Västra Götaland
Summary
PURPOSE
The two related purposes of the RE-TyPE study are:
1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and
2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital
HYPOTHESES
1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome
2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital
Eligibility Criteria
Inclusion Criteria:
1. Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital
2. Written informed consent
Exclusion Criteria from Cohort A:
1. Low risk, intermediate-low risk or high risk PE\*
2. \>48 hours since PE diagnosis
3. Expected inability to comply with the protocol (e.g. dementia)
Exclusion Criterium from Cohort B:
1\. Not geographically belonging to Sahlgrenska University Hospital
\*If biomarkers (and/or echocardiography) are not available in hemodynamically stable patients, RV/LV-ratio \>1 will be considered as preliminary intermediate-high risk. If biomarkers later fall out negative, the patient will be considered as intermediate-low risk and will be moved to Cohort B
Source: ClinicalTrials.gov (NCT07491094). StuddyBuddy aggregates publicly available trial information.